ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,369Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 2170

$1.4M Total Retail Price of All Prescriptions

Rank: 23 out of 2170

719 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 719 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 719 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 23,144 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 1,108 947 1 2
FUROSEMIDE 957 892 2 6
LISINOPRIL 897 753 3 3
SIMVASTATIN 829 752 4 1
LEVOTHYROXINE SODIUM 814 761 5 5
POTASSIUM CHLORIDE 554 485 6 16
DONEPEZIL HCL 505 505 7 32
CITALOPRAM HBR 488 458 8 19
NAMENDA 465 460 9 48
AMLODIPINE BESYLATE 457 404 10 4
WARFARIN SODIUM 435 426 11 15
METFORMIN HCL 433 350 12 8
ATORVASTATIN CALCIUM 414 334 13 12
MIRTAZAPINE 396 394 14 46
GABAPENTIN 377 326 15 14
SERTRALINE HCL 352 302 16 25
ZOLPIDEM TARTRATE 345 249 17 17
METOPROLOL TARTRATE 321 277 18 10
HYDROCODONE-ACETAMINOPHEN 316 225 S3 19 7
TRAMADOL HCL 305 241 20 18
POLYETHYLENE GLYCOL 3350 282 263 21 63
ISOSORBIDE MONONITRATE ER 276 261 22 50
LOSARTAN POTASSIUM 245 228 23 21
HYDROCHLOROTHIAZIDE 234 214 24 9
METOPROLOL SUCCINATE 227 193 25 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 223 177 26 20
PRAVASTATIN SODIUM 221 175 27 11
DILTIAZEM 24HR CD 221 221 27 82
CARBIDOPA-LEVODOPA 212 212 29 110
DIVALPROEX SODIUM 202 194 30 91
ATENOLOL 200 192 31 23
PANTOPRAZOLE SODIUM 194 168 32 39
NEXIUM 190 124 33 22
DIGOXIN 180 180 34 72
FENOFIBRATE 179 144 35 57
SPIRIVA 178 166 36 49
LANTUS 178 160 36 51
CRESTOR 171 145 38 24
AZITHROMYCIN 171 149 38 47
TAMSULOSIN HCL 167 147 40 33
CARVEDILOL 163 140 41 26
GLIMEPIRIDE 161 152 42 31
CYMBALTA 151 108 43 44
QUETIAPINE FUMARATE 150 134 44 88
CIPROFLOXACIN HCL 149 139 45 69
ALENDRONATE SODIUM 148 142 46 36
SYNTHROID 147 138 47 27
CLONIDINE HCL 145 124 48 54
ALLOPURINOL 143 118 49 29
DIOVAN 138 128 50 53
TRAZODONE HCL 135 113 51 38
RANITIDINE HCL 134 125 52 40
ENABLEX 128 116 53 264
TRIMETHOPRIM 122 122 54 331
MELOXICAM 120 103 55 28
PREDNISONE 117 110 56 41
TRICOR 114 79 57 130
PROMETHAZINE HCL 114 90 R 57 70
BISOPROLOL-HYDROCHLOROTHIAZIDE 114 105 57 116
TRIAMCINOLONE ACETONIDE 112 102 60 128
LOVASTATIN 111 111 61 34
PLAVIX 110 95 62 58
SINGULAIR 110 90 62 85
CLOPIDOGREL 109 103 64 37
FLUOXETINE HCL 108 61 65 59
BACLOFEN 104 77 66 137
OXYCODONE-ACETAMINOPHEN 103 72 S2 67 60
PROAIR HFA 101 52 68 43
DILTIAZEM ER 100 79 69 133
CLOTRIMAZOLE 98 98 70 344
FAMOTIDINE 97 92 71 96
ESCITALOPRAM OXALATE 96 83 72 75
LIPITOR 95 78 73 83
PAROXETINE HCL 92 84 74 65
ROPINIROLE HCL 90 73 75 92
ACTOS 90 85 75 108
JANTOVEN 90 90 75 104
ADVAIR DISKUS 84 58 78 45
CEPHALEXIN 83 80 79 120
NITROFURANTOIN MONO-MACRO 83 81 79 196
LEVOFLOXACIN 81 78 81 99
FLUTICASONE PROPIONATE 80 67 82 30
IPRATROPIUM-ALBUTEROL 79 79 83 131
OXYCODONE HCL 79 46 S2 83 56
RISPERIDONE 78 65 85 73
FINASTERIDE 77 77 86 122
FENTANYL 75 49 S2 87 87
NOVOLIN R 73 73 88 149
EXELON 73 73 88 119
TRAVATAN Z 69 69 90 181
DIOVAN HCT 67 55 91 76
JANUVIA 67 57 91 80
SYMBICORT 66 50 93 150
METOLAZONE 66 66 93 210
HUMALOG 65 61 95 190
CYCLOBENZAPRINE HCL 65 22 R 95 52
COMBIVENT 65 36 95 112
DILTIAZEM 24HR ER 64 52 98 135
PREMARIN 63 49 R 99 145
OXYBUTYNIN CHLORIDE 63 54 99 164
AMOX TR-POTASSIUM CLAVULANATE 62 60 101 126
BENAZEPRIL HCL 62 50 101 55
AMITRIPTYLINE HCL 61 58 R 103 61
SPIRONOLACTONE 60 51 104 71
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 105 42
LYRICA 55 34 106 90
SEROQUEL 55 48 106 168
MECLIZINE HCL 54 53 108 134
MONTELUKAST SODIUM 54 45 108 157
LEVETIRACETAM 53 45 110 109
LANTUS SOLOSTAR 53 25 110 79
METFORMIN HCL ER 53 40 110 35
LIDODERM 52 49 113 162
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.